23andMe Holding Co. is an American biotechnology company specializing in genetic testing and DNA analysis for personal genetic information and health insights. Their services enable individuals to obtain information about their genetic ancestry, predisposition to certain diseases, and health-related risk factors. The company also conducts research in the field of genetics and collaborates with pharmaceutical companies on the development of new drugs and therapies based on genetic data. Their platform is known for its high standard of privacy protection and transparency in the use of genetic data. 23andMe Holding Co. shares could be an interesting choice for investors looking for opportunities in genetic research and biotechnology.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
